Substituted imidazopyridines as HDM2 inhibitors

摘要

The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.

主权项

1. A method of treating cancer in a patient wherein the cancer is selected from the group consisting of lymphoma, acute myeloid leukemia, acute lymphoblastic leukemia, multiple myeloma, melanoma, sarcoma, liposarcoma, glioblastoma, and colorectal cancer and cancer of the breast, stomach, prostate, endometrium, kidney, bladder, colon, ovary and lung, comprising the step of administering to the patient an effective amount of a compound selected from the group consisting of: or a stereoisomer thereof; or a pharmaceutically acceptable salt thereof; or a pharmaceutically acceptable salt of the stereoisomer thereof.